Shortly after the recent introduction of intravenous urea solution into clinical neurosurgery,1 we began using this drug in selected cases of glaucoma which were resistant to conventional medical therapy.2,3 Hertel4 in 1914, and Fremont-Smith and Forbes5 in 1927, noted that hypertonic urea solution produced lowering of intraocular pressure in experimental animals, but they did not use urea for this purpose clinically. In 1957, Bunge, Danforth, and Settlage6 confirmed these results in monkeys and suggested clinical trial of this drug. Studying the effect of intravenous urea on intraocular pressure in patients with normal eyes, we were impressed with the marked reduction of pressure produced. Figure 1 shows the response in a typical normal patient. It soon became apparent that, as one might expect, reduction of elevated intraocular pressure by intravenous urea solution was temporary, unless the cause of the elevated pressure was removed before the
DAVIS MD, DUEHR PA, JAVID M. The Clinical Use of Urea for Reduction of Intraocular Pressure. Arch Ophthalmol. 1961;65(4):526–531. doi:10.1001/archopht.1961.01840020528011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: